We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

National E-Newsletter Sign up now to receive Osteoporosis Canada’s National Newsletter Osteoporosis Canada’s national e-communications showcase current organizational developments, updates on osteoporosis and bone health, new initiatives and more.

Healthcare Provider Webinar: Biologics & Biosimilars – An Overview for Healthcare Providers In the treatment of osteoporosis, biologic and biosimilar medications may be provided as part of a treatment plan. […]

St. Michael’s Hospital celebrates the 20th anniversary of the establishment of FLS St. Michael’s Hospital celebrates the 20th anniversary of the establishment of FLS St. Michael’s Hospital (SMH) in Toronto […]

WILLS AND ESTATES Help Canadians Affected by Osteoporosis by Leaving a Gift in Your Will When you leave a gift to Osteoporosis Canada in your Will, you can feel confident […]

Osteoporosis is a common but often overlooked disease in men – a broken bone may be the first sign you have it. Often, osteoporosis in men can be secondary to […]

DONATE Your Donations Go a Long Way We were the world’s first-ever osteoporosis-dedicated organization, the first to establish guidelines for long-term treatment and exercise, and the first to introduce fracture […]

A UNIQUE WAY TO CREATE AWARENESS ABOUT BONE HEALTH Attendees of Toronto Fashion Week saw something unusual on the catwalk this year: a line of innovative fashions incorporating bubble wrap! […]

Impact Report IMPACT REPORT 2022 – 2023 2022 – 2023 __________   My Story My Story Karen Noel After 25 years as a teacher, many of them working with special […]